Edition:
United Kingdom

SCYNEXIS Inc (SCYX.OQ)

SCYX.OQ on NASDAQ Stock Exchange Global Market

2.23USD
8 Dec 2017
Change (% chg)

-- (--)
Prev Close
$2.23
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
33,003
52-wk High
$3.81
52-wk Low
$1.53

Select another date:

Tue, Nov 7 2017

BRIEF-Scynexis reports third quarter 2017 financial results

* Scynexis reports third quarter 2017 financial results and provides company update

BRIEF-Scynexis presents new data related to SCY-078​

* Scynexis Inc - ‍data demonstrates broad activity and potential clinical utility of SCY-078 against invasive candida and aspergillus infections Source text for Eikon: Further company coverage:

BRIEF-Scynexis CEO Marco Taglietti​ buys 10,000 shares of co's common stock on Aug 15

* Scynexis Inc CEO‍ Marco Taglietti​ reports purchase of 10,000 shares of co's common stock on Aug 15 at $1.61 per share - SEC filing Source text: (http://bit.ly/2wj4Cck) Further company coverage:

BRIEF-Scynexis Q2 loss per share $0.16

* Scynexis reports second quarter 2017 financial results and provides company update

BRIEF-SCYNEXIS announces initiation of dosing in Phase 2 study evaluating oral SCY-078 in Vulvovaginal Candidiasis

* SCYNEXIS announces initiation of dosing in Phase 2 study evaluating oral SCY-078 in Vulvovaginal Candidiasis

Select another date: